Strategic Analysis of Antiviral Drug Development for Viral Hepatitis and HIV/AIDS
Strategic Analysis of Antiviral Drug Development for Viral Hepatitis and HIV/AIDS
Persistent Unmet Need Fuels Antiviral Drug Development for Bloodborne Pathogens
RELEASE DATE
26-Mar-2013
26-Mar-2013
REGION
Global
Global
Research Code: 9837-00-57-00-00
SKU: LS00241-GL-MR_17652
$1,500.00
In stock
SKU
LS00241-GL-MR_17652
Description
This research service focuses on antiviral/antiretroviral therapeutics for the treatment of infection with blood-borne pathogens of current global interest, specifically viral hepatitis and HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HBV, HCV, and HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology.
Table of Contents
Executive Summary
Methodology and Scope
Introduction
HBV Antiviral Market
HCV Antiviral Market
HIV Antiretroviral Market
Conclusions and Recommendations
Appendix
The Frost & Sullivan Story
Popular Topics
This research service focuses on antiviral/antiretroviral therapeutics for the treatment of infection with blood-borne pathogens of current global interest, specifically viral hepatitis and HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HBV, HCV, and HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology.
No Index | Yes |
---|---|
Podcast | No |
Author | Deborah Toscano |
WIP Number | 9837-00-57-00-00 |
Is Prebook | No |